2016 annual financial data
Travere Therapeutics 2016 Operating margin
Direct answer
Operating margin was -43.58%.
Operating income was -58,214,000 USD and net income was -47,903,000 USD.
Operating cash flow was -1,596,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 133,591,000 USD
- Operating income
- -58,214,000 USD
- Net income
- -47,903,000 USD
- Operating cash flow
- -1,596,000 USD